TAS2R38 and COVID-19: Hence, a deeper understanding of the antiviral immune pathways associated with extra-oral taste receptors could pave the way for novel therapeutic strategies for COVID-19, independent of TAS2R38 activity, aimed at (1) improving the TAS2R-mediated response, and (2) reducing TAS1Rs inhibition of TAS2Rs activity.